Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Fourth Quarter And Full Year Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. FDX
2. CBRS
3. KBH
4. HON
5. MRK
6. HTZ
7. INFY
8. HONA
9. TTWO
10. USO

Go back to Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Fourth Quarter And Full Year Financial Results

Lexicon Pharma (LXRX) Tops Q4 EPS by 21c

March 3, 2017 7:02 AM EST

Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of ($0.31), $0.21 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $23 million versus the consensus estimate of $15.64 million.

As of December 31, 2016, Lexicon had $346.5 million in cash and investments, as compared to $395.6 million as of September 30,... More